Results 241 to 250 of about 22,785 (307)
Genetic Etiologies of Dystonia with Anarthria/Aphonia
Movement Disorders Clinical Practice, EarlyView.Abstract Background
Dystonia with anarthria and/or aphonia (DAnAp) represents a distinctive phenotype manifesting across lifespan. Frequently associated with genetic disorders, early recognition is critical for diagnosis and management. Objectives
To provide practical recommendations for the clinical evaluation of patients with DAnAp, enhancing ...Anika Ménétrey, Eriberto Rayco, Maziar Emamikhah Abarghouei, Susan H. Fox, Anthony E. Lang, George M. Ibrahim, Carolina Gorodetsky, Christos Ganos +7 morewiley +1 more sourceCommodity risk assessment of <i>Hamamelis mollis</i> plants from the UK. [PDF]
EFSA JEFSA Panel on Plant Health (PLH), Civera AV, Baptista P, Berlin A, Chatzivassiliou E, Cubero J, Cunniffe N, de la Peña E, Desneux N, Di Serio F, Filipiak A, Gonthier P, Hasiów-Jaroszewska B, Jactel H, Landa BB, Maistrello L, Makowski D, Milonas P, Papadopoulos NT, Susi H, van der Gaag DJ, Debode J, Navas-Cortes JA, Kritikos C, Kormpi M, Papachristos D, Reppa C, Akrivou A, Antonatos S, Beris D, Schulz OM, Lombardo MF, Gardi C, Potting R. +33 moreeuropepmc +1 more sourceTiming of Deep Brain Stimulation and Cognitive Trajectories in GBA1‐Associated Parkinson's Disease
Movement Disorders, EarlyView.Abstract Background
Individuals with Parkinson's disease (PD) carrying GBA1 variants often develop advanced motor complications that prompt evaluation for deep brain stimulation (DBS). However, concerns about accelerated cognitive decline after DBS in GBA1 carriers complicate clinical decision making.Evridiki Asimakidou, Micol Avenali, Jan O. Aasly, Mitra Afshari, Roy N. Alcalay, Sharlet Anderson, Carlo Alberto Artusi, Bryan Bernard, Marco Bozzali, Susan Bressman, Giovanna Calandra‐Buonaura, Francesco Cavallieri, Roberto Cilia, Jean‐Christoph Corvol, Antoniangela Cocco, Rob M.A. de Bie, Debra Ehrlich, Roberto Eleopra, Thomas Foltynie, Alessio Di Fonzo, Giulia Giannini, Christopher Goetz, Deborah Hall, Joohi Jimenez‐Shahed, Leonardo Lopiano, Vanessa Lythe, Maria Chiara Malaguti, Francesca Mameli, Graziella Mangone, Karen Marder, M. Maral Mouradian, Augusto Rini, Luisa Sambati, Rachel Saunders‐Pullman, Vicki Lynn Shanker, Francesca Spagnolo, Marie‐Laure Welter, Roberta Zangaglia, Gian Pal, Enza Maria Valente, PARKNET Study Group, Giada Cuconato, Ilaria Palmieri, Alberto Imarisio, Pierfrancesco Mitrotti, Francesca Valentino, Claudio Pacchetti, Gabriele Imbalzano, Claudia Ledda, Silvia Gallo, Pietro Cortelli, Luca Baldelli, Ilaria Cani, Raffaella Minardi, Valerio Carelli, Franco Valzania, Edoardo Monfrini, Filippo Cogiamanian, Chiara Longo, Fabiana Colucci, Luigi M. Romito, Marco Liccari +61 morewiley +1 more sourceSomatic genomic profiling reveals clinically relevant heterogeneity in <i>RAS</i>-mutant sporadic medullary thyroid carcinoma. [PDF]
J Clin Transl EndocrinolRuggeri E, Censi S, Bertazza L, Benetti A, Cortese F, Piva I, Clausi C, Marotta V, Galuppini F, Giannella A, Pennelli G, Iacobone M, Vitale M, Ceolotto G, Barollo S, Mian C. +15 moreeuropepmc +1 more sourceAutomated Magnetic Resonance Volumetry to Measure Multiple System Atrophy Disease Progression in Clinical Trials
Movement Disorders, EarlyView.Abstract Background
Recent studies have reported longitudinal brain atrophy in multiple system atrophy (MSA) in relatively small patient cohorts. Objective
To compare longitudinal regional brain volume and clinical changes as endpoint measures for MSA clinical trials.Andrea Quattrone, Ida Wilkens, Zeyu Zhu, Irfan A. Qureshi, Nicolai Franzmeier, Günter U. Höglinger, for the M‐STAR Study Group, Phillip Low, Wolfgang Singer, Stuart Isaacson, Susan Perlman, Tao Xie, Zbigniew Wszolek, Diana Kerwin, Diana Apateurova, Theresa Zesiewicz, Roy Freeman, Rajesh Pahwa, Nikolaus McFarland, Eric Molho, Michael Geschwind, Rajeev Kumar, Sana Aslam, Dignity Health, Jee Bang, Aaron Ellenbogen, Italo Biaggioni, Andres Deik, Patricio Millar Vernetti, Jose‐Alberto Palma‐Carazo, Horacio Kaufmann, Pravin Khemani, Jeremy Schmahmann, Xuemei Huang, Irene Litvan, Mitchell Miglis, Deborah Hall, Sheng‐Han Kuo, Stewart Factor, Steven Vernino, Werner Poewe, Caroline Thun‐Hohenstein, Sophie Drapier, Alexandre Eusebio, Wassilios Meissner, Anne Pavy Le Traon, Christine Tranchant, Daniela Berg, Jost‐Julian Rumpf, Karla Eggert, Alfons Schnitzler, Lars Tönges, Jens Ebentheuer, Claudia Trenkwalder, Inga Claus, Tobias Warnecke, Guenter Hoeglinger, Annika Spottke, Nicola Pavese, Alessio DiFonzo, Paolo Barone, Huw Morris, Klaus Seppi +62 morewiley +1 more sourceCharacterising fine‐scale habitat associations for range expanding species with limited data: a case study on the West Nile Virus vector, Culex modestus
Oikos, EarlyView.The ecological and epidemiological consequences of species expanding into new areas are growing concomitantly with climate change. Those aiming to monitor species expanding in range must make optimal use of finite resources to deliver effective surveillance capable of detecting new incursions and range expansions.Susanna Cant, Owen Jones, Maisie Vollans, Maximilian Ayling, Nyall Jamieson, Alexander G. C. Vaux, Jolyon M. Medlock, Thomas Ward, Julie Day, Robert S. Paton +9 morewiley +1 more sourceUsing participatory scenario planning to explore the synergies and trade‐offs from upland treescape expansion
People and Nature, EarlyView.Abstract The future of land use in the UK uplands is highly debated, with growing interest in increasing tree cover and other land use changes, alongside a desire to maintain traditional land use patterns and practices. Treescape expansion is likely to result in synergies and trade‐offs between different outcomes, so integrating stakeholder preferences Melissa Minter, Susan Baker, Euan Bowditch, Sheena Carlisle, Natasha Constant, Alix Syder, Tom Finch +6 morewiley +1 more source